Type 2 diabetes and retinopathy

A population-based study suggests that treatment with a statin may slow the risk for new and worsening retinopathy in patients with diabetes and dyslipidemia.

Meta-analysis data show that intensive blood pressure control significantly reduces the risk for developing diabetic retinopathy in patients with type 2 diabetes.

Obese patients with type 2 diabetes who undergo bariatric surgery achieve large reductions in their risk for microvascular complications, shows a real-world study.

The CLEOPATRA trial results show that wearing a mask that emits blue–green light during sleep does not reduce the progression of non-central diabetic macular edema.

Researchers have developed a screening tool, the Liverpool Risk Calculation Engine, which offers individualized, variable-interval, risk-based screening for diabetic retinopathy and has sufficient performance for local introduction into practice, according to a modeling study.

Changes in the structure and pattern of the retinal vasculature are an early indicator of diabetic retinopathy, and improve the ability of established risk factors to predict which patients will develop it, say researchers.

Results of the CLARITY trial suggest that aflibercept treatment may produce better visual outcomes than laser photocoagulation in patients with proliferative diabetic retinopathy.

Individuals with diabetic macular edema or proliferative diabetic retinopathy are more likely to develop and die from cardiovascular disease than those without either condition, results of a systematic review and meta-analysis show.

A substantial proportion of diabetes patients experience improvements in diabetic retinopathy while receiving anti-vascular endothelial growth factor treatment, shows the latest analysis from DRCR.net.

A meta-analysis from the Collaborators on Trials of Lowering Glucose group supports intensive glycemic control for improved microvascular outcomes in patients with type 2 diabetes.

Results of a US study suggest that implementation of a primary care-based teleretinal diabetic retinopathy screening program could improve access to screening and maximize efficiency.

Research shows that the largest long-term reductions in microvascular complications around 20 years after bariatric surgery for obesity are seen among patients who had prediabetes at the time of surgery.

A deep learning algorithm is highly accurate for the detection of diabetic retinopathy in retinal fundus photographs, researchers report in JAMA.

Analysis of the Maastricht study reveals microvascular dysfunction in the eyes and skin of people with prediabetes.

Semaglutide significantly reduces the likelihood of adverse cardiovascular outcomes among patients with Type 2 diabetes at high cardiovascular risk, the SUSTAIN-6 study shows.

Nearly 2 decades after the launch of the Steno-2 study, patients with complicated diabetes given intensive multifactorial treatment have gained nearly 8 years of life, say the researchers.